|
|
| (17 intermediate revisions by 8 users not shown) |
| Line 1: |
Line 1: |
| {{Pulmonary embolism}}
| | #Redirect [[Pulmonary embolism natural history, complications and prognosis]] |
|
| |
| {{CMG}}
| |
|
| |
| '''Associate Editors-in-Chief:''' [[User:Ujjwal Rastogi|Ujjwal Rastogi, MBBS]] [mailto:urastogi@perfuse.org]
| |
|
| |
| '''''Synonyms and keywords:''''' PE
| |
| | |
| ==[[Pulmonary embolism follow-up/recurrence|Follow-Up/Recurrence]]==
| |
| | |
| After a first PE, the search for secondary causes is usually brief. Only when a second PE occurs, and especially when this happens while still under [[anticoagulant]] therapy, a further search for underlying conditions is undertaken. This will include testing ("thrombophilia screen") for Factor V Leiden mutation, antiphospholipid antibodies, protein C and S and antithrombin levels, and later prothrombin mutation, MTHFR mutation, Factor VIII concentration and rarer inherited [[coagulation]] abnormalities.
| |
| | |
| For prevention of recurrences, when patients are admitted to medical wards or when patients undergo surgery, their physicians should prescribe prophylactic measures to prevent PE. After hospital discharge, prophylaxis should continue for about a month for patients at high risk of thromboembolism.
| |
|
| |
| ==References==
| |
| {{reflist|2}}
| |
|
| |
| [[Category:Hematology]]
| |
| [[Category:Pulmonology]]
| |
| [[Category:Cardiology]]
| |
| [[Category:Emergency medicine]]
| |
|
| |
| {{WH}}
| |
| {{WS}}
| |